USANA Health Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of USANA Health Sciences generated cash of $70,641,000, which is less than the previous year. Cash used in financing activities reached the amount of -$14,237,000 last year. Net change in cash is therefore $41,926,000.
Cash Flow
| 2012 | 92.80M | -8.27M | -64.54M |
|---|---|---|---|
| 2013 | 98.89M | -21.58M | -10.16M |
| 2016 | 111.46M | -25.12M | -49.15M |
| 2016 | 137.03M | -31.88M | -64.86M |
| 2017 | 123.78M | -12.90M | -50.31M |
| 2018 | 152.11M | -69.00M | -105.27M |
| 2019 | 126.73M | 47.49M | -152.05M |
| 2021 | 160.40M | -33.96M | -59.44M |
| 2022 | 103.90M | -12.37M | -30.08M |
| 2023 | 70.64M | -11.97M | -14.23M |
USNA Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 291.32M | 243.65M | 237.68M | 217.23M | 250.53M | 175.77M | 143.21M | 111.12M | 70.83M | 50.35M |
Operating activities | ||||||||||
Net income | 63.78M | 69.35M | 124.66M | 100.52M | 126.22M | 62.53M | 100.04M | 94.67M | 79.02M | 66.43M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 20.39M | 21.41M | 22.50M | 23.00M | 16.84M | 16.11M | 13.48M | 9.97M | 9.04M | 8.82M |
Stock-based compensation expense | 14.59M | 13.33M | 14.39M | 15.54M | 0 | 15.48M | 16.54M | 11.08M | 7.62M | 10.21M |
| Deferred income tax benefit | 14.59M | 13.33M | 14.39M | 15.54M | 0 | 15.48M | 16.54M | 11.08M | 7.62M | 10.21M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 2.35M | 21.87M | -16.78M | 12.99M | -23.10M | 6.05M | -1.03M | -23.07M | -11.78M | 1.37M |
Accounts payable | -428K | -2.65M | 6.07M | 1.83M | -1.72M | 3.04M | -1.34M | 2.48M | 2.79M | -985K |
Cash generated by operating activities | 70.64M | 103.90M | 160.40M | 126.73M | 152.11M | 123.78M | 137.03M | 111.46M | 98.89M | 92.80M |
Investing activities | ||||||||||
Purchases Of Investments | -1.27M | 0 | -21.08M | -1.66M | -86.39M | 0 | 0 | -3.87M | -8.64M | 0 |
Investments In Property Plant And Equipment | -14.49M | -10.4M | -15.09M | -16.56M | -11.43M | -13.22M | -32.69M | -23.72M | -8.05M | -8.43M |
Acquisitions Net | 0 | -6.53M | 6K | 17K | 381K | 22K | 11K | -8.45M | 0 | 0 |
Cash generated by investing activities | -11.97M | -12.37M | -33.96M | 47.49M | -69.00M | -12.90M | -31.88M | -25.12M | -21.58M | -8.27M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -11.59M | -25.38M | -57.02M | -150M | -105.37M | -50M | -64.61M | -61.18M | -18.08M | -68.29M |
Repayments of term debt | 792K | 0 | -60M | -65K | 0 | 0 | -73.7M | 0 | 0 | -1.84M |
Cash used in financing activities | -14.23M | -30.08M | -59.44M | -152.05M | -105.27M | -50.31M | -64.86M | -49.15M | -10.16M | -64.54M |
Net Change In Cash | 41.92M | 47.66M | 78.24M | 20.45M | -33.30M | 71.35M | 32.56M | 32.08M | 66.50M | 20.48M |
Cash at end of period | 333.24M | 291.32M | 315.93M | 237.68M | 217.23M | 247.13M | 175.77M | 143.21M | 137.34M | 70.83M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |